Filing Details

Accession Number:
0001209191-21-055881
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-09-14 16:08:34
Reporting Period:
2021-09-10
Accepted Time:
2021-09-14 16:08:34
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1662579 C4 Therapeutics Inc. CCCC Biological Products, (No Disgnostic Substances) (2836) 475617627
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1768223 Jolie Siegel C/O C4 Therapeutics, Inc.
490 Arsenal Way #200
Watertown MA 02472
Chief Legal Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-09-10 12,500 $4.98 12,500 No 4 M Direct
Common Stock Disposition 2021-09-10 12,500 $50.00 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2021-09-10 12,500 $0.00 12,500 $4.98
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
271,321 2030-07-02 No 4 M Direct
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2021.
  2. 20% of this option vested and became exercisable on July 1, 2021, with the remainder vesting in 16 equal quarterly installments thereafter.